09/05/2024
8:01 PM | Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:45 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Filed by)
| Form SC 13D/A | |
08/30/2024
4:24 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:40 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:53 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:59 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/19/2024
4:35 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:14 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:07 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:51 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:32 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:15 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
4:41 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
4:48 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:58 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:39 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
7:56 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:14 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:17 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:21 PM | Peters Malte (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:11 PM | Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:13 PM | Ketchum John B (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:16 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:27 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:18 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:14 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:21 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
8:34 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
8:32 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
8:31 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
8:32 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. |
04/29/2024
3:17 PM | Tango Therapeutics (Filer)
| Form DEF 14A | |
04/17/2024
3:53 PM | Tango Therapeutics (Filer)
| Form PRE 14A | |
04/08/2024
7:46 AM | Southpoint Capital Advisors LP (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
03/18/2024
7:27 AM | Tango Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2024
6:19 AM | Tango Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2024
6:08 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:52 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
11:32 AM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
8:04 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:08 PM | Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:09 PM | Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:14 PM | Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:00 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:29 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:07 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:49 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
4:23 PM | BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/17/2023
6:41 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4/A | |
10/17/2023
5:04 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
2:33 PM | EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2023
2:42 PM | EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/11/2023
8:22 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
6:22 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4/A | |
10/10/2023
8:42 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
8:43 PM | Boxer Capital, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
4:16 PM | EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G | |
09/11/2023
11:15 PM | Tango Therapeutics (Filer)
| Form EFFECT | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
